Evidence map›Paper›PMID 27092776›Full record

ArticlePloS one2016

A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study.

Lucia Vernerova, Frantisek Spoutil, Miroslav Vlcek, Katarina Krskova, Adela Penesova, Milada Meskova, Andrea Marko, Katarina Raslova, Branislav Vohnout, Jozef Rovensky and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Association betweenAging · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Associations ofCentral-European journal of immunology · 2019
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Lucia VernerovaInstitute of Clinical and Translational Research, Biomedical Centre, Slovak Academy of Sciences, Bratislava, Slovakia.ORCID http://orcid.org/0000-0001-6087-2175
Frantisek SpoutilInstitute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic.
Miroslav VlcekInstitute of Clinical and Translational Research, Biomedical Centre, Slovak Academy of Sciences, Bratislava, Slovakia.
Katarina KrskovaInstitute of Clinical and Translational Research, Biomedical Centre, Slovak Academy of Sciences, Bratislava, Slovakia.
Adela PenesovaInstitute of Clinical and Translational Research, Biomedical Centre, Slovak Academy of Sciences, Bratislava, Slovakia.
Milada MeskovaInstitute of Clinical and Translational Research, Biomedical Centre, Slovak Academy of Sciences, Bratislava, Slovakia.
Andrea MarkoInstitute of Clinical and Translational Research, Biomedical Centre, Slovak Academy of Sciences, Bratislava, Slovakia.
Katarina RaslovaSlovak Medical University, Bratislava, Slovakia.
Branislav VohnoutSlovak Medical University, Bratislava, Slovakia.
Jozef RovenskyNational Institute of Rheumatic Diseases, Piešťany, Slovakia.
Zdenko Killinger5th Department of Internal Medicine, Medical Faculty of Comenius University, Bratislava, Slovakia.
Ivana Jochmanova1st Department of Internal Medicine, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Košice, Slovakia.
Ivica Lazurova1st Department of Internal Medicine, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Košice, Slovakia.
Guenter SteinerDepartment of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Josef SmolenDepartment of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Richard ImrichInstitute of Clinical and Translational Research, Biomedical Centre, Slovak Academy of Sciences, Bratislava, Slovakia.
Biomedical Research Center of the Slovak Academy of Sciences · SKMedical University of Vienna · ATSlovak Medical University · SKUniversity of Pavol Jozef Šafárik · SKComenius University Bratislava · SKCzech Academy of Sciences · CZNational Institute of Rheumatic Diseases · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA).

methodsA total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in the study. The presence of shared epitope (SE) in HLA-DRB1 and 11 SNPs (PTPN22 C/T (rs2476601), STAT4 G/T (rs7574865), CTLA4 A/G (rs3087243), TRAF1/C5 A/G (rs3761847), IRF5 T/C (rs10488631), TNFAIP3 C/T (rs5029937), AFF3 A/T (rs11676922), PADI4 C/T (rs2240340), CD28 T/C (rs1980422), CSK G/A (rs34933034) and FCGR3A A/C (rs396991), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and clinical status was analysed using the LDA and RDA.

resultsHLA-DRB1, PTPN22, STAT4, IRF5 and PADI4 significantly discriminated between RA patients and healthy controls in LDA. The correlation between RA diagnosis and the explanatory variables in the model was 0.328 (Trace = 0.107; F = 13.715; P = 0.0002). The risk variants of IRF5 and CD28 genes were found to be common determinants for seropositivity in RDA, while positivity of RF alone was associated with the CTLA4 risk variant in heterozygous form. The correlation between serologic status and genetic determinants on the 1st ordinal axis was 0.468, and 0.145 on the 2nd one (Trace = 0.179; F = 6.135; P = 0.001). The risk alleles in AFF3 gene together with the presence of ACPA were associated with higher clinical severity of RA.

conclusionsThe association among multiple risk variants related to T cell receptor signalling with seropositivity may play an important role in distinct clinical phenotypes of RA. Our study demonstrates that multiparametric analyses represent a powerful tool for investigation of mutual relationships of potential risk factors in complex diseases such as RA.

Indexed as

AdultAllelesArthritis, RheumatoidAutoantibodiesCase-Control StudiesCD28 AntigensFemaleGenetic Predisposition to DiseaseGenotypeHumansInterferon Regulatory FactorsMaleMiddle AgedPolymorphism, Single NucleotideRheumatoid FactorRisk FactorsAutoantibodiesCD28 AntigensInterferon Regulatory FactorsIRF5 protein, humanRheumatoid Factor

Identifiers

PMID27092776
PMCPMC4836711
OpenAlexW2341970630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.